Work

Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Year: 2012

Type: review

Abstract: In spite of its long history, immunotherapy of cancer has led to only a few regulatory approved treatments, starting with interleukin (IL)-2 in renal cancer and melanoma and interferon in melanoma....

Source: Human Vaccines & Immunotherapeutics

DOI: 10.4161/hv.21382

Authors: Dirk J. Reitsma, Austin J. Combest

Institution: Pharmaceutical Product Development (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,175

OpenAlex ID: W1982955486

FWCI: 0.341

Cites: 37

Cited by: 18

Related to: 10